Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Yang, Xi  [Clear All Filters]
Journal Article
Cai W-W, Wang L-J, Li S-J, Zhang X-P, Li T-T, Wang Y-H, Yang X, Xie J, Li J-D, Liu S-J, et al. Effective tracking of bone mesenchymal stem cells in vivo by magnetic resonance imaging using melanin-based gadolinium(3+) nanoparticles. J Biomed Mater Res A. 2016.
Ye G, Guan H, Karush J, Wang F, Xu X, Mao H, Huang X, Yang X, Peng P, Ba Y, et al. Effects of Ca(2+)-activated potassium and inward rectifier potassium channel on the differentiation of endothelial progenitor cells from human peripheral blood. Mol Biol Rep. 2014.
Zhang Y, An J, Liu M, Li N, Wang W, Yao H, Li N, Yang X, Sun Y, Xu N, et al. Efficient Isolation, Culture, Purification and Stem Cell Expression Profiles of Primary Tumor Cells Derived from Uterine Cervical Squamous Cell Carcinoma. Am J Reprod Immunol. 2020:e13251.
Pang L, Liu Z, Wei F, Cai C, Yang X. Improving cardiotoxicity prediction in cancer treatment: integration of conventional circulating biomarkers and novel exploratory tools. Arch Toxicol. 2020.
Zhu S, Rao X, Qian Y, Chen J, Song R, Yan H, Yang X, Hu J, Wang X, Han Z, et al. Liver endothelial Heg regulates vascular/biliary network patterning and metabolic zonation via Wnt signaling. Cell Mol Gastroenterol Hepatol. 2022.
White MC, Pang L, Yang X. MicroRNA-mediated maturation of human pluripotent stem cell-derived cardiomyocytes: Towards a better model for cardiotoxicity?. Food Chem Toxicol. 2016.
Pang L, Cai C, Aggarwal P, Wang D, Vijay V, Bagam P, Blamer J, Matter A, Turner A, Ren L, et al. Predicting oncology Drug-Induced cardiotoxicity with Donor-Specific iPSC-CMs-a proof-of-Concept study with doxorubicin. Toxicol Sci. 2024.
Zhu G-X, Xiao H-Y, Guo Q-J, Zhang Z-Y, Yang X, Kong J. [Subcellular Distribution and Chemical Forms of Heavy Metals in Three Types of Compositae Plants from Lead-Zinc Tailings Area]. Huan Jing Ke Xue. 2017;38(7):3054-3060.
Yang X, Ribeiro AJS, Pang L, Strauss DG. Use of Human iPSC-CMs in Nonclinical Regulatory Studies for Cardiac Safety Assessment. Toxicol Sci. 2022.
Pang L, Sager P, Yang X, Shi H, Sannajust F, Brock M, Wu JC, Abi-Gerges N, Lyn-Cook B, Berridge BR, et al. Workshop Report: FDA Workshop on Improving Cardiotoxicity Assessment With Human-Relevant Platforms. Circ Res. 2019;125(9):855-867.